Virtue Capital Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-608
| Closed | -$229K | – | 365 |
|
|
2023
Q3 | $229K | Hold |
608
| – | – | 0.04% | 356 |
|
|
2023
Q2 | $229K | Sell |
608
-58
| -9% | -$21.9K | 0.04% | 353 |
|
|
2023
Q1 | $290K | Buy |
666
+7
| +1% | +$3.05K | 0.05% | 314 |
|
|
2022
Q4 | $277K | Buy |
+659
| New | +$277K | 0.04% | 302 |
|
|
2022
Q3 | – | Sell |
-532
| Closed | -$263K | – | 261 |
|
|
2022
Q2 | $263K | Sell |
532
-1,416
| -73% | -$700K | 0.04% | 210 |
|
|
2022
Q1 | $1.1M | Sell |
1,948
-196
| -9% | -$110K | 0.17% | 148 |
|
|
2021
Q4 | $1.62M | Sell |
2,144
-18
| -0.8% | -$13.6K | 0.24% | 102 |
|
|
2021
Q3 | $1.61M | Sell |
2,162
-133
| -6% | -$99.2K | 0.29% | 83 |
|
|
2021
Q2 | $1.48M | Buy |
2,295
+174
| +8% | +$112K | 0.3% | 89 |
|
|
2021
Q1 | $1.21M | Buy |
2,121
+146
| +7% | +$83.4K | 0.29% | 110 |
|
|
2020
Q4 | $1.15M | Sell |
1,975
-513
| -21% | -$299K | 0.28% | 108 |
|
|
2020
Q3 | $1.28M | Sell |
2,488
-109
| -4% | -$56.2K | 0.32% | 94 |
|
|
2020
Q2 | $1.17M | Buy |
+2,597
| New | +$1.17M | 0.27% | 112 |
|
|
2020
Q1 | – | Sell |
-1,451
| Closed | -$537K | – | 52 |
|
|
2019
Q4 | $537K | Buy |
+1,451
| New | +$537K | 0.15% | 132 |
|